Cargando…
Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer
The objective of this study was to determine the proportion of phase 3 clinical trials investigating a systemic therapy for patients with prostate, breast, lung, or colorectal cancer that excluded patients with Chronic Kidney Disease (CKD) and the exclusion criteria chosen, if any. A search was cond...
Autores principales: | Delaye, Matthieu, Rousseau, Adrien, Try, Mélanie, Massard, Christophe, Campedel, Luca, Hilmi, Marc, Bagnis, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939176/ https://www.ncbi.nlm.nih.gov/pubmed/36156460 http://dx.doi.org/10.1002/cam4.5171 |
Ejemplares similares
-
Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?
por: Boilève, Alice, et al.
Publicado: (2021) -
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
por: Watson, Sarah, et al.
Publicado: (2018) -
Hepatitis C Therapy in Renal Patients: Who, How, When?
por: Isnard Bagnis, Corinne, et al.
Publicado: (2016) -
Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV
por: Heron, Jack Edward, et al.
Publicado: (2020) -
Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review
por: Bagnis, Corinne Isnard, et al.
Publicado: (2015)